All Cosmos Bio-Tech Holding (TPE:4148) Cyclically Adjusted Revenue per Share: NT$43.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4148 All Cosmos Bio-Tech Holding Corp TPE:4148
84 GF Score
Price NT$31.90
GF Value NT$45.39
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is All Cosmos Bio-Tech Holding Cyclically Adjusted Revenue per Share?

All Cosmos Bio-Tech Holding TPE:4148 +1.75% 84 Cyclically Adjusted Revenue per Share is NT$43.28 as of Mar. 2026. GuruFocus rates TPE:4148 with a GF Score™ of 84/100 and a GF Value™ of NT$45.39 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

All Cosmos Bio-Tech Holding's adjusted revenue per share for the three months ended in Mar. 2026 was NT$8.016. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$43.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, All Cosmos Bio-Tech Holding's average Cyclically Adjusted Revenue Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-19), All Cosmos Bio-Tech Holding's current stock price is NT$31.90. All Cosmos Bio-Tech Holding's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was NT$43.28. All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio of today is 0.74.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of All Cosmos Bio-Tech Holding was 1.24. The lowest was 0.68. And the median was 1.01.


All Cosmos Bio-Tech Holding  (TPE:4148) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=31.90/43.28
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of All Cosmos Bio-Tech Holding was 1.24. The lowest was 0.68. And the median was 1.01.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


All Cosmos Bio-Tech Holding Cyclically Adjusted Revenue per Share Related Terms


All Cosmos Bio-Tech Holding Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for All Cosmos Bio-Tech Holding's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

All Cosmos Bio-Tech Holding Cyclically Adjusted Revenue per Share Chart

All Cosmos Bio-Tech Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 42.07 42.49 42.83

All Cosmos Bio-Tech Holding Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.81 42.88 43.02 42.83 43.28

TPE:4148 vs CTVA, CF, MOS: Cyclically Adjusted Revenue per Share Comparison

For the Agricultural Inputs subindustry, All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


All Cosmos Bio-Tech Holding Cyclically Adjusted PS Ratio vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio falls into.


TPE:4148
84GF Score
All Cosmos Bio-Tech Holding Corp TPE:4148
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

All Cosmos Bio-Tech Holding Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, All Cosmos Bio-Tech Holding's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.016/330.2130*330.2130
=8.016

Current CPI (Mar. 2026) = 330.2130.

All Cosmos Bio-Tech Holding Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 9.906 241.018 13.572
201609 9.423 241.428 12.888
201612 6.622 241.432 9.057
201703 7.705 243.801 10.436
201706 9.196 244.955 12.397
201709 10.280 246.819 13.753
201712 8.040 246.524 10.769
201803 10.394 249.554 13.753
201806 11.228 251.989 14.713
201809 11.273 252.439 14.746
201812 6.956 251.233 9.143
201903 5.257 254.202 6.829
201906 8.681 256.143 11.191
201909 6.693 256.759 8.608
201912 5.534 256.974 7.111
202003 3.195 258.115 4.087
202006 5.874 257.797 7.524
202009 7.079 260.280 8.981
202012 8.245 260.474 10.453
202103 6.087 264.877 7.588
202106 8.430 271.696 10.246
202109 8.125 274.310 9.781
202112 9.964 278.802 11.801
202203 9.882 287.504 11.350
202206 13.534 296.311 15.082
202209 18.434 296.808 20.509
202212 11.743 296.797 13.065
202303 11.540 301.836 12.625
202306 11.755 305.109 12.722
202309 9.069 307.789 9.730
202312 7.727 306.746 8.318
202403 7.050 312.332 7.454
202406 6.868 314.175 7.219
202409 10.867 315.301 11.381
202412 10.462 315.605 10.946
202503 8.384 319.799 8.657
202506 10.939 322.561 11.199
202509 12.310 324.800 12.515
202512 12.338 324.054 12.572
202603 8.016 330.213 8.016

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$43.28 mean?
All Cosmos Bio-Tech Holding (TPE:4148) has a Cyclically Adjusted Revenue per Share of NT$43.28 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on All Cosmos Bio-Tech Holding and its competitors.
Is All Cosmos Bio-Tech Holding's Cyclically Adjusted Revenue per Share too high?
All Cosmos Bio-Tech Holding's current Cyclically Adjusted Revenue per Share is NT$43.28. Overall, All Cosmos Bio-Tech Holding has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does All Cosmos Bio-Tech Holding's Cyclically Adjusted Revenue per Share compare to CTVA and CF?
All Cosmos Bio-Tech Holding's Cyclically Adjusted Revenue per Share of NT$43.28 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Agriculture company?
A good Cyclically Adjusted Revenue per Share depends on the Agriculture industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on All Cosmos Bio-Tech Holding and its competitors. All Cosmos Bio-Tech Holding's current Cyclically Adjusted Revenue per Share is NT$43.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is All Cosmos Bio-Tech Holding stock overvalued right now?
Based on GuruFocus' analysis, All Cosmos Bio-Tech Holding (TPE:4148) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$45.39, compared to a current price of NT$31.90 — trading 29.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$43.28. All Cosmos Bio-Tech Holding's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For All Cosmos Bio-Tech Holding (TPE:4148), the current Cyclically Adjusted Revenue per Share is NT$43.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is All Cosmos Bio-Tech Holding (TPE:4148) Overvalued in 2026?

Based on GuruFocus' analysis, All Cosmos Bio-Tech Holding stock appears to be undervalued. The current stock price of NT$31.90 is trading 29.7% below its estimated GF Value™ of NT$45.39. GuruFocus considers All Cosmos Bio-Tech Holding to be Significantly Undervalued.

Key valuation signals for TPE:4148:

  • Cyclically Adjusted Revenue per Share: NT$43.28
  • GF Value™: NT$45.39 vs. price of NT$31.90 (29.7% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the TPE:4148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


All Cosmos Bio-Tech Holding Business Description

Address PLO 650, Jalan Keluli 7, Pasir Gudang Industrial Estate, Johor Bahru, JHR, MYS, 81700
All Cosmos Bio-Tech Holding Corp is involved in a wide range of industries, mainly divided into 4 focused areas, including agriculture, waste reutilization, health care and pharmaceutical, and research and development of microbials. The group's reportable segments are All Cosmos Industries Sdn. Bhd. (ACI), Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. (SSHF) and others. The majority of its revenue is generated from the ACI segment, which operates as a manufacturer and marketer of Bio-Organic and Bio-Chemical fertilizers. It offers various organic, bio-chemical, bio-control, and chemical fertilizers. Geographically, the group derives maximum revenue from Malaysia and the rest from other markets.
84GF Score

Get the complete analysis for TPE:4148

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.90
Price
NT$45.39
GF Value